基础医学与临床 ›› 2025, Vol. 45 ›› Issue (10): 1291-1297.doi: 10.16352/j.issn.1001-6325.2025.10.1291

• 研究论文 • 上一篇    下一篇

松果菊苷减轻乙型肝炎模型大鼠肝损伤

王维1*, 穆宝龙2, 张文双1, 吴清雷1   

  1. 河北北方学院附属第二医院 1.感染疾病科; 2.肾内科,河北 张家口 075000
  • 收稿日期:2024-09-20 修回日期:2024-12-02 出版日期:2025-10-05 发布日期:2025-09-22
  • 通讯作者: *j48uan@163.com
  • 基金资助:
    河北省2024年度医学科学研究课题计划(20241127)

Echinacoside attenuates liver injury in a rat model of hepatitis B

WANG Wei1*, MU Baolong2, ZHANG Wenshuang1, WU Qinglei1   

  1. 1. Department of Infectious Diseases; 2. Department of Nephrology, the Second Affiliated Hospital of Hebei North University Affiliated Second Hospital, Zhangjiakou 075000, China
  • Received:2024-09-20 Revised:2024-12-02 Online:2025-10-05 Published:2025-09-22
  • Contact: *j48uan@163.com

摘要: 目的 探讨松果菊苷(Ech)对乙型肝炎大鼠肝损伤的影响。方法 将SD大鼠分为对照组(control)、乙型肝炎(HBV,尾静脉注射5 mL/kg HBV病毒,2次/周, 共连续3 周)、Ech低(Ech-L)和高(Ech-H)剂量干预HBV组(灌胃,剂量分别为8.33和33.32 mg/kg)、阳性药(拉米夫定,lamivudine,灌胃10 mg/kg)和Ech-H+BKM120(40 mg/kg BKM120)干预HBV组,每组12只。给药1次/d,共持续8周。检测血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)活性;ELISA检测血清中γ-干扰素(IFN-γ)、白细胞介素(IL-4)水平;流式细胞测量术检测外周血中Th1/Th2;染色质免疫共沉淀检测肝组织中HBV DNA表达;HE染色检测肝组织病理变化并进行损伤评分;Western blot检测肝组织中磷酸化磷脂酰肌醇3激酶(p-PI3K)、磷酸化蛋白激酶B(p-AKT)蛋白。结果 乙型肝炎组较对照组而言,肝组织中肝细胞肿胀,核染色过多,肝小叶结构紊乱,病理损伤评分、血清中AST、ALT活性及IL-4水平、外周血中Th2、肝组织中HBV DNA表达升高,血清中IFN-γ水平、外周血中Th1、Th1/Th2、肝组织中p-PI3K、p-AKT蛋白降低(P<0.05);Ech-L、Ech-H、拉米夫定处理均可减轻HBV大鼠肝细胞肿胀,使部分肝索结构清晰,降低了病理损伤评分、血清中AST、ALT活性及IL-4水平、外周血中Th2、肝组织中HBV DNA表达,升高了血清中IFN-γ水平、外周血中Th1、Th1/Th2、肝组织中p-PI3K、p-AKT蛋白表达(P<0.05);BKM120减弱了高剂量Ech对乙型肝炎大鼠肝损伤的改善作用。结论 Ech改善乙型肝炎大鼠肝损伤,其机制可能与激活PI3K/AKT通路有关。

关键词: 松果菊苷, 磷脂酰肌醇3激酶/蛋白激酶B通路, 乙型肝炎, 肝损伤, 免疫

Abstract: Objective To investigate the effect of Echinacoside (Ech) on liver injury in hepatitis B rats. Methods SD rats were divided into control group, Hepatitis B (HBV, 5 mL/kg HBV virus was injected into the tail vein twice a week for 3 consecutive weeks), low (Ech-L) and high (Ech-H) doses of Ech were injected into the stomach for HBV (8.33 and 33.32 mg/kg, respectively), HBV group was treated with positive drugs (lamivudine, 10 mg/kg) and Ech-H+BKM120 (40 mg/kg BKM120), with 12 animals in each group. The drug was administered once a day for 8 weeks. The activity of ALT and AST in serum of were detected. Serum level of gamma-interferon (IFN-γ) and interleukin (IL-4) was detected by ELISA; Flow cytometry was applied to detect Th1/Th2 in peripheral blood; Chromatin immunoprecipitation was applied to detect HBV DNA expression in liver tissue; HE staining was used to detect the pathological changes of liver tissue and score the damage; Western blot was applied to detect phosphorylated phosphatidylinositol 3 kinase (p-PI3K), phosphorylated protein kinase B (p-AKT) proteins in liver tissue. Results Compared with the control group, hepatocytes in the hepatitis B group were swollen,nuclear staining was excessive, hepatic lobular structure was disorganized, pathological injury score, serum AST, ALT activity, IL-4 level, peripheral blood Th2, HBV DNA expression in liver tissue were all increased. Serum IFN-γ level, Th1, Th1/Th2 in peripheral blood, p-PI3K and p-AKT protein in liver tissue were all decreased (P<0.05); Treatment with Ech-L, Ech-H and lamivudine reduced the swelling of HBV rat hepatocytes, cleared the structure of some liver cords, reduced pathological injury score, the activity of AST, ALT and IL-4 levels in serum, Th2 in peripheral blood and HBV DNA in liver tissue; The level of serum IFN-γ, Th1, Th1/Th2 in peripheral blood, and protein expression p-PI3K and p-AKT protein in liver tissue were increased (P<0.05). BKM120 attenuated the ameliorative effect of high-dose Ech on hepatitis B-induced liver injury in rats. Conclusions Ech ameliorates liver injury in rats with hepatitis B, and the mechanism may be related to the activation of the PI3K/AKT pathway.

Key words: echinacoside, phosphatidylinositol-3 kinase/protein kinase B pathway, hepatitis B, liver injury, immune

中图分类号: